🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-05-30
Trial ID
NCT03131648
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
Oral selexipag is commercially available in several countries for the treat...
Status
Terminated
Location
St. Vincent Medical Group, Inc.
Start Date
2021-02-26
Trial ID
NCT03942211
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2017-06-12
Trial ID
NCT03160885
Treatments Being Tested
Primary Objective: To demonstrate the efficacy of dupilumab on itch respon...
Status
Completed
Location
Investigational Site Number :8400054
Start Date
2020-01-16
Trial ID
NCT04202679
The objective of this study is to assess the safety of upadacitinib combine...
Status
Completed
Location
Ichinomiya Municipal Hospital /ID# 205942
Start Date
2018-10-27
Trial ID
NCT03661138
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of upadaci...
Status
Active Not Recruiting
Location
Total Skin and Beauty Derm Ctr /ID# 200548
Start Date
2018-08-09
Trial ID
NCT03568318
Treatments Being Tested
Primary objective: To demonstrate that tralokinumab in combination with to...
Status
Completed
Location
Leo Pharma Investigationel Site
Start Date
2018-12-13
Trial ID
NCT03761537
Treatments Being Tested
Assess the efficacy of several subcutaneous doses of nemolizumab in moderat...
Status
Completed
Location
Galderma Investigational site
Start Date
2017-06-14
Trial ID
NCT03100344
Treatments Being Tested